UniProt ID | AP2B_HUMAN | |
---|---|---|
UniProt AC | Q92481 | |
Protein Name | Transcription factor AP-2-beta | |
Gene Name | TFAP2B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 460 | |
Subcellular Localization | Nucleus . | |
Protein Description | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.. | |
Protein Sequence | MHSPPRDQAAIMLWKLVENVKYEDIYEDRHDGVPSHSSRLSQLGSVSQGPYSSAPPLSHTPSSDFQPPYFPPPYQPLPYHQSQDPYSHVNDPYSLNPLHQPQQHPWGQRQRQEVGSEAGSLLPQPRAALPQLSGLDPRRDYHSVRRPDVLLHSAHHGLDAGMGDSLSLHGLGHPGMEDVQSVEDANNSGMNLLDQSVIKKVPVPPKSVTSLMMNKDGFLGGMSVNTGEVFCSVPGRLSLLSSTSKYKVTVGEVQRRLSPPECLNASLLGGVLRRAKSKNGGRSLRERLEKIGLNLPAGRRKAANVTLLTSLVEGEAVHLARDFGYICETEFPAKAVSEYLNRQHTDPSDLHSRKNMLLATKQLCKEFTDLLAQDRTPIGNSRPSPILEPGIQSCLTHFSLITHGFGAPAICAALTALQNYLTEALKGMDKMFLNNTTTNRHTSGEGPGSKTGDKEEKHRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MHSPPRDQAA -----CCCCHHHHHH | 34.99 | 101546443 | |
15 | Ubiquitination | QAAIMLWKLVENVKY HHHHHHHHHHHHCCH | 38.40 | - | |
21 | Sumoylation | WKLVENVKYEDIYED HHHHHHCCHHHHCCC | 55.28 | 12072434 | |
21 | Sumoylation | WKLVENVKYEDIYED HHHHHHCCHHHHCCC | 55.28 | - | |
26 | Phosphorylation | NVKYEDIYEDRHDGV HCCHHHHCCCCCCCC | 24.89 | 22817900 | |
92 | Ubiquitination | PYSHVNDPYSLNPLH CCCCCCCCCCCCCCC | 18.53 | 21963094 | |
94 | Ubiquitination | SHVNDPYSLNPLHQP CCCCCCCCCCCCCCC | 27.36 | 22817900 | |
120 | Phosphorylation | EVGSEAGSLLPQPRA HHHHHHHHCCCCHHH | 33.51 | 50565749 | |
223 | Phosphorylation | DGFLGGMSVNTGEVF CCCCCCEEECCCCEE | 18.58 | 20068231 | |
226 | Phosphorylation | LGGMSVNTGEVFCSV CCCEEECCCCEEEEC | 32.34 | 20068231 | |
232 | Phosphorylation | NTGEVFCSVPGRLSL CCCCEEEECCCCHHH | 21.63 | 20068231 | |
238 | Phosphorylation | CSVPGRLSLLSSTSK EECCCCHHHCCCCCC | 26.38 | 51163003 | |
241 | Phosphorylation | PGRLSLLSSTSKYKV CCCHHHCCCCCCEEE | 36.54 | 22617229 | |
242 | Phosphorylation | GRLSLLSSTSKYKVT CCHHHCCCCCCEEEE | 36.35 | 29255136 | |
243 | Phosphorylation | RLSLLSSTSKYKVTV CHHHCCCCCCEEEEH | 26.34 | 23663014 | |
244 | Phosphorylation | LSLLSSTSKYKVTVG HHHCCCCCCEEEEHH | 35.62 | 30576142 | |
245 | Ubiquitination | SLLSSTSKYKVTVGE HHCCCCCCEEEEHHH | 49.53 | 21963094 | |
246 | Phosphorylation | LLSSTSKYKVTVGEV HCCCCCCEEEEHHHH | 15.51 | 20068231 | |
247 | Ubiquitination | LSSTSKYKVTVGEVQ CCCCCCEEEEHHHHH | 34.86 | 22817900 | |
254 | Ubiquitination | KVTVGEVQRRLSPPE EEEHHHHHHHCCCHH | 22.07 | 21963094 | |
256 | Ubiquitination | TVGEVQRRLSPPECL EHHHHHHHCCCHHHH | 23.56 | 22817900 | |
258 | Phosphorylation | GEVQRRLSPPECLNA HHHHHHCCCHHHHCH | 36.28 | 24732914 | |
266 | Phosphorylation | PPECLNASLLGGVLR CHHHHCHHHHHHHHH | 24.05 | 24732914 | |
277 | Phosphorylation | GVLRRAKSKNGGRSL HHHHHHHHCCCCHHH | 30.30 | - | |
288 | Ubiquitination | GRSLRERLEKIGLNL CHHHHHHHHHHCCCC | 7.24 | 21963094 | |
290 | Ubiquitination | SLRERLEKIGLNLPA HHHHHHHHHCCCCCC | 46.82 | 22817900 | |
300 | Ubiquitination | LNLPAGRRKAANVTL CCCCCCCHHHCCCEE | 31.86 | 21963094 | |
301 | Ubiquitination | NLPAGRRKAANVTLL CCCCCCHHHCCCEEE | 50.95 | - | |
302 | Ubiquitination | LPAGRRKAANVTLLT CCCCCHHHCCCEEEE | 11.49 | 22817900 | |
354 | Ubiquitination | PSDLHSRKNMLLATK HHHHHHHHHHHHHHH | 50.12 | - | |
442 | Phosphorylation | NTTTNRHTSGEGPGS CCCCCCCCCCCCCCC | 34.88 | 27732954 | |
443 | Phosphorylation | TTTNRHTSGEGPGSK CCCCCCCCCCCCCCC | 28.81 | 27732954 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
258 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
21 | K | Sumoylation |
| 12072434 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP2B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LZTR1_HUMAN | LZTR1 | physical | 20211142 | |
SSBP4_HUMAN | SSBP4 | physical | 20211142 | |
UBC9_HUMAN | UBE2I | physical | 12072434 | |
YETS4_HUMAN | YEATS4 | physical | 16698963 | |
CBP_HUMAN | CREBBP | physical | 25294805 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
169100 | Char syndrome (CHAR) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...